Japan Nerve Repair And Regeneration Market Size & Outlook
- MedTech
- Neurology Devices
- Nerve Repair And Regeneration Market Outlook
- Neurology Devices
Japan Nerve Repair And Regeneration Market, 2018-2030 (US$M)
Global Market
Related Markets
Ask a question about the nerve repair and regeneration market
Japan nerve repair and regeneration market highlights
- The Japan nerve repair and regeneration market generated a revenue of USD 282.5 million in 2023 and is expected to reach USD 710.8 million by 2030.
- The Japan market is expected to grow at a CAGR of 14.1% from 2024 to 2030.
- In terms of segment, neurostimulation and neuromodulation devices was the largest revenue generating product in 2023.
- Biomaterials is the most lucrative product segment registering the fastest growth during the forecast period.
Nerve repair and regeneration market data book summary
| Market revenue in 2023 | USD 282.5 million |
| Market revenue in 2030 | USD 710.8 million |
| Growth rate | 14.1% (CAGR from 2023 to 2030) |
| Largest segment | Neurostimulation and neuromodulation devices |
| Fastest growing segment | Biomaterials |
| Historical data | 2018 - 2022 |
| Base year | 2023 |
| Forecast period | 2024 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Biomaterials, Neurostimulation and Neuromodulation Devices |
| Key market players worldwide | Axogen Inc, Stryker Corp, St. Jude Medical, Baxter International Inc, Boston Scientific Corp, Integra Lifesciences Holdings Corp, Medtronic PLC, Polyganics, LivaNova PLC |
Other key industry trends
- In terms of revenue, Japan accounted for 3.1% of the global nerve repair and regeneration market in 2023.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
- In Asia Pacific, India nerve repair and regeneration market is projected to lead the regional market in terms of revenue in 2030.
- Japan is the fastest growing regional market in Asia Pacific and is projected to reach USD 710.8 million by 2030.
The nerve repair and regeneration market is growing at a rapid rate in Japan. This can be attributed to technological advancements and rising government initiatives to reduce the risk of neurological diseases. Increase in investments in pharmaceutical companies is anticipated to boost the market growth.
In June 2019, Mesoblast Limited announced that it has expanded its collaboration with JCR Pharmaceuticals Co. Ltd. in Japan to include the use of Mesenchymal Stem Cells (MSCs) in the treatment of newborns with neonatal hypoxic ischemic encephalopathy, a condition in which the brain lacks sufficient blood supply and oxygen (HIE).
In Japan, JCR is launching TEMCELL4 HS Inj., an allogeneic MSC product, for the treatment of steroid-refractory acute graft versus host disease (aGVHD) in children and adults. Mesoblast will receive royalties on all TEMCELL product sales for all licensed indications under the terms of the agreement.
No credit card required*
Customize the Report
20% free customization
- Include
- Countries, segments, points
- Tailor
- To your product definition
- Extend
- Deeper competitor detail
- Or
- A fully bespoke study
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Nerve Repair And Regeneration Market Scope
Nerve Repair And Regeneration Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|---|---|---|---|
| Baxter International Inc | View profile | 60,000 | One Baxter Parkway, Deerfield, IL, United States, 60015 | www.baxter.com |
| Medtronic PLC | View profile | 95,000 | Lower Hatch Street, 20 On Hatch, Dublin, Ireland, 2 | www.medtronic.com |
| Stryker Corp | View profile | 52,000 | 1941 Stryker Way, Portage, MI, United States, 49002 | www.stryker.com |
| Boston Scientific Corp | View profile | 48,000 | 300 Boston Scientific Way, Marlborough, MA, United States, 01752-1234 | www.bostonscientific.com |
| Integra Lifesciences Holdings Corp | View profile | 3,946 | 1100 Campus Road, Princeton, NJ, United States, 08540 | www.integralife.com |
| St. Jude Medical | View profile | 10001+ | Saint Paul, Minnesota, United States, North America | www.sjm.com |
| LivaNova PLC | View profile | 2,900 | 20 Eastbourne Terrace, London, United Kingdom, W2 6LG | www.livanova.com |
| Axogen Inc | View profile | 428 | 13631 Progress Boulevard, Suite 400, Alachua, FL, United States, 32615 | www.axogeninc.com |
| Polyganics | View profile | 11-50 | Groningen, Groningen, The Netherlands, Europe | www.polyganics.com |
Japan Nerve Repair And Regeneration Market Outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to Nerve Repair And Regeneration Market Outlook will help companies and investors design strategic landscapes.
Neurostimulation And Neuromodulation Devices was the largest segment with a revenue share of 67.12% in 2023.
Horizon Databook has segmented the Japan nerve repair and regeneration market based on biomaterials, neurostimulation and neuromodulation devices covering the revenue growth of each sub-segment from 2018 to 2030.
The nerve repair and regeneration market is growing at a rapid rate in Japan. This can be attributed to technological advancements and rising government initiatives to reduce the risk of neurological diseases. Increase in investments in pharmaceutical companies is anticipated to boost the market growth.
In June 2019, Mesoblast Limited announced that it has expanded its collaboration with JCR Pharmaceuticals Co. Ltd. in Japan to include the use of Mesenchymal Stem Cells (MSCs) in the treatment of newborns with neonatal hypoxic ischemic encephalopathy, a condition in which the brain lacks sufficient blood supply and oxygen (HIE).
In Japan, JCR is launching TEMCELL4 HS Inj., an allogeneic MSC product, for the treatment of steroid-refractory acute graft versus host disease (aGVHD) in children and adults. Mesoblast will receive royalties on all TEMCELL product sales for all licensed indications under the terms of the agreement.
- Japan Nerve Repair And Regeneration Market Product Outlook (Revenue, USD Million , 2018-2030)
- Biomaterials
- Neurostimulation and Neuromodulation Devices
- Japan Nerve Repair And Regeneration Market Surgery Outlook (Revenue, USD Million , 2018-2030)
- Direct Nerve Repair/Neurorrhaphy
- Nerve Grafting
- Stem Cell Therapy
- Neurostimulation and Neuromodulation Surgeries
Reasons to subscribe to Nerve Repair And Regeneration Market Outlook databook
- Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
- Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
- Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
- Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
- Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Nerve Repair And Regeneration Market Outlook databook
- Our clientele includes a mix of Nerve Repair And Regeneration Market Outlook companies, investment firms, advisory firms & academic institutions.
- 30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
- Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
- The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the Japan Nerve Repair And Regeneration Market Outlook, including forecasts for subscribers. This country databook contains high-level insights into Japan Nerve Repair And Regeneration Market Outlook from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Japan Nerve Repair And Regeneration Market, 2018-2030 (US$M)
Japan nerve repair and regeneration market statistics, by product, 2018-2030 (US$M)
